{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:43:08Z","timestamp":1782283388076,"version":"3.54.5"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009898","name":"Beckett-Fonden","doi-asserted-by":"publisher","award":["20-2-6614"],"award-info":[{"award-number":["20-2-6614"]}],"id":[{"id":"10.13039\/501100009898","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Holms Memory Foundation","award":["21057"],"award-info":[{"award-number":["21057"]}]},{"DOI":"10.13039\/501100007437","name":"TrygFonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007437","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Royal Library, Copenhagen University Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The global prevalence of chronic hepatitis B is more than 300 million people, and in Denmark, 17,000 people are estimated to have chronic hepatitis B. Untreated, chronic hepatitis B can lead to the development of liver cirrhosis and liver cancer. There is no curable therapy. In persons with obesity and chronic hepatitis B infection, the development of hepatic steatosis imposes a double burden on the liver, leading to an increased risk of cirrhosis and liver cancer. In patients without chronic hepatitis B, exercise interventions have shown beneficial effects on hepatic steatosis through improvements in fat fraction of the liver, insulin resistance, fatty acid metabolism, and glucose metabolism, as well as activation of liver-induced regulatory protein secretion (hepatokines) after the exercise intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate in persons with chronic hepatitis B and hepatic steatosis:<jats:list list-type=\"bullet\"><jats:list-item><jats:p>Primary: Whether exercise will decrease the fat fraction of the liver.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Secondary: If exercise will affect hepatokine secretion and if it will improve lipid- and glucose metabolism, liver status, markers of inflammation, body composition, and blood pressure.<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A randomized, controlled, clinical intervention trial consisting of 12\u00a0weeks of aerobic exercise training or no intervention. Thirty persons with chronic hepatitis B and hepatic steatosis will be randomized 1:1. Before and after the intervention, participants will undergo an MRI scan of the liver, blood sampling, oral glucose tolerance test, fibroscan, VO2<jats:sub>max<\/jats:sub>test, DXA scan, blood pressure measurements, and optional liver biopsy. Lastly, a hormone infusion test with somatostatin and glucagon to increase the glucagon\/insulin ratio for stimulating secretion of circulating hepatokines will be performed. The training program includes three weekly training sessions of 40\u00a0min\/session over 12\u00a0weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This trial, investigating high-intensity interval training in persons with chronic hepatitis B and hepatic steatosis, is the first exercise intervention trial performed on this group of patients. If exercise reduces hepatic steatosis and induces other beneficial effects of clinical markers in this group of patients, there might be an indication to recommend exercise as part of treatment. Furthermore, the investigation of the effect of exercise on hepatokine secretion will provide more knowledge on the effects of exercise on the liver.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>Danish Capital Regions committee on health research ethics reference: H-21034236 (version 1.4 date: 19\u201307-2022) and ClinicalTrials.gov: NCT05265026.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13063-023-07385-y","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T08:02:20Z","timestamp":1686643340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of aerobic exercise training on the fat fraction of the liver in persons with chronic hepatitis B and hepatic steatosis: Trial protocol for a randomized controlled intervention trial\u2014\u00a0The FitLiver study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5747-1581","authenticated-orcid":false,"given":"Sofie","family":"Jespersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Plomgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Madsbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Espe","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bandholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente Klarlund","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Krogh-Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"issue":"9","key":"7385_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"GBD 2019 Hepatitis B Collaborators","year":"2022","unstructured":"GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796\u2013829.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"25","key":"7385_CR2","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.3748\/wjg.v23.i25.4587","volume":"23","author":"YJ Chen","year":"2017","unstructured":"Chen YJ, Chen KW, Shih YL, Su FY, Lin YP, Meng FC, et al. Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study. World J Gastroenterol. 2017;23(25):4587.","journal-title":"World J Gastroenterol"},{"issue":"28","key":"7385_CR3","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.3748\/wjg.v24.i28.3163","volume":"24","author":"YH Yi","year":"2018","unstructured":"Yi YH, Kim YJ, Lee SY, Cho BM, Cho YH, Lee JG. Health behaviors of Korean adults with hepatitis B: Findings of the 2016 Korean National Health and Nutrition Examination Survey. World J Gastroenterol. 2018;24(28):3163\u201370.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"7385_CR4","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2337\/dc15-1081","volume":"38","author":"WT Cefalu","year":"2015","unstructured":"Cefalu WT, Bray GA, Home PD, Garvey WT, Klein S, Pi-Sunyer FX, et al. Advances in the science, treatment, and prevention of the disease of obesity: Ref lections from a diabetes care editors\u2019 expert forum. Diabetes Care. 2015;38(8):1567\u201382.","journal-title":"Diabetes Care"},{"issue":"7","key":"7385_CR5","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, International Consensus Panel. A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020;158(7):1999-2014.e1.","journal-title":"Gastroenterology."},{"issue":"1","key":"7385_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1365-2036.2007.03538.x","volume":"27","author":"E Tsochatzis","year":"2008","unstructured":"Tsochatzis E, Papatheodoridis GV, Manesis EK, Kafiri G, Tiniakos DG, Archimandritis AJ. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2008;27(1):80\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"7385_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, YounossiSanyal ZAJ, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123\u201333.","journal-title":"Hepatology"},{"issue":"5","key":"7385_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389\u201398.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"7385_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","volume":"59","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia. 2016;59(6):1121\u201340.","journal-title":"Diabetologia."},{"issue":"4","key":"7385_CR10","first-page":"542","volume":"37","author":"P Charatcharoenwitthaya","year":"2017","unstructured":"Charatcharoenwitthaya P, Pongpaibul A, Kaosombatwattana U, Bhanthumkomol P, Bandidniyamanon W, Pausawasdi N, et al. The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response. Liver Int Off J Int Assoc Study Liver. 2017;37(4):542\u201351.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"1","key":"7385_CR11","first-page":"70","volume":"39","author":"L Zhu","year":"2019","unstructured":"Zhu L, Jiang J, Zhai X, Baecker A, Peng H, Qian J, et al. Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study. Liver Int Off J Int Assoc Study Liver. 2019;39(1):70\u201380.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"9","key":"7385_CR12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1440-1746.2011.06801.x","volume":"26","author":"MV Machado","year":"2011","unstructured":"Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol. 2011;26(9):1361\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"26","key":"7385_CR13","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.3748\/wjg.v27.i26.3971","volume":"27","author":"YW Shi","year":"2021","unstructured":"Shi YW, Yang RX, Fan JG. Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion. World J Gastroenterol. 2021;27(26):3971\u201383.","journal-title":"World J Gastroenterol"},{"issue":"23","key":"7385_CR14","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.21037\/atm-21-3052","volume":"9","author":"D Jiang","year":"2021","unstructured":"Jiang D, Chen C, Liu X, Huang C, Yan D, Zhang X, et al. Concurrence and impact of hepatic steatosis on chronic hepatitis B patients: a systematic review and meta-analysis. Ann Transl Med. 2021;9(23):1718.","journal-title":"Ann Transl Med"},{"issue":"3","key":"7385_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/jgh.13536","volume":"32","author":"AWH Chan","year":"2017","unstructured":"Chan AWH, Wong GLH, Chan HY, Tong JHM, Yu YH, Choi PCL, et al. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B. J Gastroenterol Hepatol. 2017;32(3):667\u201376.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"7385_CR16","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1210\/jc.2015-1966","volume":"100","author":"P Portillo-Sanchez","year":"2015","unstructured":"Portillo-Sanchez P, Bril F, Maximos M, Lomonaco R, Biernacki D, Orsak B, et al. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. J Clin Endocrinol Metab. 2015;100(6):2231\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"7385_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd3988","volume":"12","author":"S Crunkhorn","year":"2013","unstructured":"Crunkhorn S. Metabolic disorders: Breaking the links between inflammation and diabetes. Nat Rev Drug Discov. 2013;12(4):261.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"7385_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/MCO.0b013e32830460c2","volume":"11","author":"M Navab","year":"2008","unstructured":"Navab M, Gharavi N, Watson AD. Inflammation and metabolic disorders. Curr Opin Clin Nutr Metab Care. 2008;11(4):459\u201364.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"7121","key":"7385_CR19","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860\u20137.","journal-title":"Nature"},{"key":"7385_CR20","first-page":"18","volume":"315","author":"A Asghar","year":"2017","unstructured":"Asghar A, Sheikh N. Role of immune cells in obesity induced low grade inflammation and insulin resistance Cellular Immunology. Academic Press Inc. 2017;315:18\u201326.","journal-title":"Academic Press Inc"},{"issue":"3","key":"7385_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/oby.21003","volume":"23","author":"RW Grant","year":"2015","unstructured":"Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity. 2015;23(3):512\u20138.","journal-title":"Obesity"},{"issue":"6","key":"7385_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1155\/2013\/508023","volume":"35","author":"S Tang","year":"2013","unstructured":"Tang S, Liu Z, Zhang Y, He Y, Pan D, Liu Y, et al. Rather than Rs1800796 polymorphism, expression of interleukin-6 is associated with disease progression of chronic HBV infection in a Chinese Han population. Dis Markers. 2013;35(6):799\u2013805.","journal-title":"Dis Markers"},{"issue":"9","key":"7385_CR23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1742-1241.2006.00936.x","volume":"60","author":"I Kiki","year":"2006","unstructured":"Kiki I, Yilmaz O, Erdem F, Gundogdu M, Demircan B, Bilici M. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores. Int J Clin Pract. 2006;60(9):1075\u20139.","journal-title":"Int J Clin Pract"},{"issue":"3","key":"7385_CR24","first-page":"496","volume":"40","author":"J Zhang","year":"2020","unstructured":"Zhang J, Lin S, Jiang D, Li M, Chen Y, Li J, et al. Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors? Liver Int Off J Int Assoc Study Liver. 2020;40(3):496\u2013508.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"9","key":"7385_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"RCR Meex","year":"2017","unstructured":"Meex RCR, Watt MJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol. 2017;13(9):509\u201320.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"7385_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2012.258","volume":"9","author":"N Stefan","year":"2013","unstructured":"Stefan N, H\u00e4ring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol. 2013;9(3):144\u201352.","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"7385_CR27","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/liv.14104","volume":"39","author":"L Mak","year":"2019","unstructured":"Mak L, Lee C, Cheung K, Wong DK, Liu F, Hui RW, et al. Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogue. Liver Int. 2019;39(7):1217\u201325.","journal-title":"Liver Int"},{"issue":"5","key":"7385_CR28","doi-asserted-by":"publisher","first-page":"e63517","DOI":"10.1371\/journal.pone.0063517","volume":"8","author":"KH Kim","year":"2013","unstructured":"Kim KH, Kim SH, Min YK, Yang HM, Lee JB, Lee MS. Acute exercise induces FGF21 expression in mice and in healthy humans. PLoS One. 2013;8(5):e63517.","journal-title":"PLoS One"},{"issue":"4","key":"7385_CR29","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/0016-5085(95)90212-0","volume":"108","author":"K Kogure","year":"1995","unstructured":"Kogure K, Omata W, Kanzaki M, Zhang YQ, Yasuda H, Mine T, et al. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology. 1995;108(4):1136\u201342.","journal-title":"Gastroenterology"},{"issue":"1","key":"7385_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/mt.2014.200","volume":"23","author":"JR Mendell","year":"2015","unstructured":"Mendell JR, Sahenk Z, Malik V, Gomez AM, Flanigan KM, Lowes LP, et al. A phase 1\/2a follistatin gene therapy trial for becker muscular dystrophy. Mol Ther J Am Soc Gene Ther. 2015;23(1):192\u2013201.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"4","key":"7385_CR31","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0168-8278(00)00029-5","volume":"34","author":"S Patella","year":"2001","unstructured":"Patella S, Phillips DJ, de Kretser DM, Evans LW, Groome NP, Sievert W. Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis. J Hepatol. 2001;34(4):576\u201383.","journal-title":"J Hepatol"},{"issue":"10","key":"7385_CR32","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.molmet.2017.06.018","volume":"6","author":"B Ingerslev","year":"2017","unstructured":"Ingerslev B, Hansen JS, Hoffmann C, Clemmesen JO, Secher NH, Scheler M, et al. Angiopoietin-like protein 4 is an exercise-induced hepatokine in humans, regulated by glucagon and cAMP. Mol Metab. 2017;6(10):1286\u201395.","journal-title":"Mol Metab"},{"key":"7385_CR33","doi-asserted-by":"publisher","first-page":"1037948","DOI":"10.3389\/fendo.2022.1037948","volume":"13","author":"P Plomgaard","year":"2022","unstructured":"Plomgaard P, Hansen JS, Townsend LK, Gudiksen A, Secher NH, Clemmesen JO, et al. GDF15 is an exercise-induced hepatokine regulated by glucagon and insulin in humans. Front Endocrinol. 2022;13:1037948.","journal-title":"Front Endocrinol"},{"issue":"11","key":"7385_CR34","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1194\/jlr.C200010-JLR200","volume":"43","author":"K Yoshida","year":"2002","unstructured":"Yoshida K, Shimizugawa T, Ono M, Furukawa H. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res. 2002;43(11):1770\u20132.","journal-title":"J Lipid Res"},{"issue":"4","key":"7385_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/labmed\/lmaa089","volume":"52","author":"J Chen","year":"2021","unstructured":"Chen J, Tang D, Xu C, Niu Z, Li H, Li Y, et al. Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma. Lab Med. 2021;52(4):381\u20139.","journal-title":"Lab Med"},{"issue":"4","key":"7385_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/13813455.2016.1202985","volume":"122","author":"TM Langleite","year":"2016","unstructured":"Langleite TM, Jensen J, Norheim F, Gulseth HL, Tangen DS, Kolnes KJ, et al. Insulin sensitivity, body composition and adipose depots following 12 w combined endurance and strength training in dysglycemic and normoglycemic sedentary men. Arch Physiol Biochem. 2016;122(4):167\u201379.","journal-title":"Arch Physiol Biochem"},{"issue":"12","key":"7385_CR37","first-page":"1097","volume":"129","author":"K Hallsworth","year":"2015","unstructured":"Hallsworth K, Thoma C, Hollingsworth KG, Cassidy S, Anstee QM, Day CP, et al. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. Clin Sci Lond Engl 1979. 2015;129(12):1097\u2013105.","journal-title":"Clin Sci Lond Engl 1979"},{"issue":"16","key":"7385_CR38","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.4254\/wjh.v7.i16.2041","volume":"7","author":"M Whitsett","year":"2015","unstructured":"Whitsett M. Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review. World J Hepatol. 2015;7(16):2041.","journal-title":"World J Hepatol"},{"issue":"1","key":"7385_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm0102-75","volume":"8","author":"V Wallenius","year":"2002","unstructured":"Wallenius V, Wallenius K, Ahr\u00e9n B, Rudling M, Carlsten H, Dickson SL, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med. 2002;8(1):75\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"7385_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cmet.2017.05.018","volume":"26","author":"S Theurich","year":"2017","unstructured":"Theurich S, Tsaousidou E, Hanssen R, Lempradl AM, Mauer J, Timper K, et al. IL-6\/Stat3-Dependent Induction of a Distinct, Obesity-Associated NK Cell Subpopulation Deteriorates Energy and Glucose Homeostasis. Cell Metab. 2017;26(1):171-184.e6.","journal-title":"Cell Metab"},{"key":"7385_CR41","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1381\/096089204323093345","volume":"14","author":"DR Cottam","year":"2004","unstructured":"Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: Implications and effect of weight loss. Obesity Surgery. 2004;14:589\u2013600.","journal-title":"Obesity Surgery."},{"key":"7385_CR42","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cyto.2016.08.033","volume":"88","author":"L Ma","year":"2016","unstructured":"Ma L, Zhang H, Yin Y Ling, Guo W Zhi, Ma Y Qun, Wang Y Bo, et al. Role of interleukin-6 to differentiate sepsis from non-infectious systemic inflammatory response syndrome. Cytokine. 2016;88:126\u201335.","journal-title":"Cytokine."},{"issue":"Pt 3","key":"7385_CR43","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/j.1469-7793.1998.949bp.x","volume":"508","author":"K Ostrowski","year":"1998","unstructured":"Ostrowski K, Rohde T, Zacho M, Asp S, Pedersen BK. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol. 1998;508(Pt 3):949\u201353.","journal-title":"J Physiol"},{"issue":"529 Pt 1","key":"7385_CR44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1469-7793.2000.00237.x","volume":"15","author":"A Steensberg","year":"2000","unstructured":"Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Klarlund PB. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol. 2000;15(529 Pt 1):237\u201342.","journal-title":"J Physiol"},{"issue":"2","key":"7385_CR45","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1159\/000430386","volume":"37","author":"C Xia","year":"2015","unstructured":"Xia C, Liu Y, Chen Z, Zheng M. Involvement of Interleukin 6 in Hepatitis B Viral Infection. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2015;37(2):677\u201386.","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"issue":"11","key":"7385_CR46","doi-asserted-by":"publisher","first-page":"e0142599","DOI":"10.1371\/journal.pone.0142599","volume":"10","author":"GA Palumbo","year":"2015","unstructured":"Palumbo GA, Scisciani C, Pediconi N, Lupacchini L, Alfalate D, Guerrieri F, et al. IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome. PLoS One. 2015;10(11):e0142599.","journal-title":"PLoS One"},{"issue":"1","key":"7385_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/M17-0046","volume":"167","author":"I Boutron","year":"2017","unstructured":"Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P. CONSORT NPT Group. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. Ann Intern Med. 2017;167(1):40\u20137.","journal-title":"Ann Intern Med"},{"issue":"12","key":"7385_CR48","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/bjsports-2021-105058","volume":"56","author":"T Bandholm","year":"2022","unstructured":"Bandholm T, Thorborg K, Ardern CL, Christensen R, Henriksen M. Writing up your clinical trial report for a scientific journal: the REPORT trial guide for effective and transparent research reporting without spin. Br J Sports Med. 2022;56(12):683\u201391.","journal-title":"Br J Sports Med"},{"issue":"23","key":"7385_CR49","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1136\/bjsports-2016-096651","volume":"50","author":"SC Slade","year":"2016","unstructured":"Slade SC, Dionne CE, Underwood M, Buchbinder R. Consensus on Exercise Reporting Template (CERT): Explanation and Elaboration Statement. Br J Sports Med. 2016;50(23):1428\u201337.","journal-title":"Br J Sports Med"},{"issue":"3","key":"7385_CR50","doi-asserted-by":"publisher","first-page":"e001156","DOI":"10.1136\/bmjsem-2021-001156","volume":"7","author":"F Foged","year":"2021","unstructured":"Foged F, Rasmussen IE, Bj\u00f8rn Budde J, Rasmussen RS, Rasmussen V, Lyngb\u00e6k M, et al. Fidelity, tolerability and safety of acute high-intensity interval training after hospitalisation for COVID-19: a randomised cross-over trial. BMJ Open Sport Exerc Med. 2021;7(3):e001156.","journal-title":"BMJ Open Sport Exerc Med"},{"issue":"1","key":"7385_CR51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13063-018-2637-0","volume":"19","author":"RH Christensen","year":"2018","unstructured":"Christensen RH, Wedell-Neergaard AS, Lehrskov LL, Leg\u00e5rd GE, Dorph EB, Nymand S, et al. The role of exercise combined with tocilizumab in visceral and epicardial adipose tissue and gastric emptying rate in abdominally obese participants: protocol for a randomised controlled trial. Trials. 2018;19(1):266.","journal-title":"Trials"},{"issue":"1","key":"7385_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.18869\/acadpub.johe.2.1.2.20","volume":"2","author":"Moghiseh M, Dept., of Occupational Health, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran., Habibi E, Dept., of Occupational Health, School of Health, Isfahan University of Medical Science, Isfahan, Iran., Aramesh N, Inorganic Chemistry, Yasuj University, Yasuj, Iran","year":"2013","unstructured":"Moghiseh M, Dept., of Occupational Health, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran., Habibi E, Dept., of Occupational Health, School of Health, Isfahan University of Medical Science, Isfahan, Iran., Aramesh N, Inorganic Chemistry, Yasuj University, Yasuj, Iran, et al. The association between VO2max and heart rate of casting industry workers. J Occup Health Epidemiol. 2013;2(1):20\u20136.","journal-title":"J Occup Health Epidemiol."},{"issue":"4","key":"7385_CR53","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1249\/mss.0b013e3180304570","volume":"39","author":"J Helgerud","year":"2007","unstructured":"Helgerud J, H\u00f8ydal K, Wang E, Karlsen T, Berg P, Bjerkaas M, et al. Aerobic High-Intensity Intervals Improve V\u02d9O2max More Than Moderate Training. Med Sci Sports Exerc. 2007;39(4):665\u201371.","journal-title":"Med Sci Sports Exerc"},{"issue":"Suppl 2","key":"7385_CR54","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1007\/s40279-014-0253-z","volume":"44","author":"SL Halson","year":"2014","unstructured":"Halson SL. Monitoring training load to understand fatigue in athletes. Sports Med Auckl NZ. 2014;44(Suppl 2):S139-147.","journal-title":"Sports Med Auckl NZ"},{"issue":"7","key":"7385_CR55","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1249\/MSS.0b013e318213fefb","volume":"43","author":"CE Garber","year":"2011","unstructured":"Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for develop-ing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334\u201359.","journal-title":"Med Sci Sports Exerc."},{"issue":"Suppl 2","key":"7385_CR56","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1007\/s40279-014-0253-z","volume":"44","author":"SL Halson","year":"2014","unstructured":"Halson SL. Monitoring training load to understand fatigue in athletes. Sports Med Auckl NZ. 2014;44(Suppl 2):S139-147.","journal-title":"Sports Med Auckl NZ"},{"issue":"8","key":"7385_CR57","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/eci.12781","volume":"47","author":"BK Pedersen","year":"2017","unstructured":"Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Invest. 2017;47(8):600\u201311.","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"7385_CR58","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","volume":"14","author":"GA Borg","year":"1982","unstructured":"Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377\u201381.","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"7385_CR59","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1148\/radiol.2021202912","volume":"298","author":"HH Hu","year":"2021","unstructured":"Hu HH, Yokoo T, Bashir MR, Sirlin CB, Hernando D, Malyarenko D, et al. Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform Multivendor Phantom Study. Radiology. 2021;298(3):640\u201351.","journal-title":"Radiology"},{"issue":"2","key":"7385_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1148\/radiol.2017170550","volume":"286","author":"T Yokoo","year":"2018","unstructured":"Yokoo T, Serai SD, Pirasteh A, Bashir MR, Hamilton G, Hernando D, et al. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. Radiology. 2018;286(2):486\u201398.","journal-title":"Radiology"},{"issue":"12","key":"7385_CR61","first-page":"1097","volume":"129","author":"K Hallsworth","year":"2015","unstructured":"Hallsworth K, Thoma C, Hollingsworth KG, Cassidy S, Anstee QM, Day CP, et al. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. Clin Sci Lond Engl 1979. 2015;129(12):1097\u2013105.","journal-title":"Clin Sci Lond Engl 1979"},{"issue":"2","key":"7385_CR62","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/oby.2009.274","volume":"18","author":"GJ van der Heijden","year":"2010","unstructured":"van der Heijden GJ, Wang ZJ, Chu ZD, Sauer PJJ, Haymond MW, Rodriguez LM, et al. A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese Hispanic adolescents. Obes Silver Spring Md. 2010;18(2):384\u201390.","journal-title":"Obes Silver Spring Md"},{"issue":"1","key":"7385_CR63","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jhep.2015.02.022","volume":"63","author":"SE Keating","year":"2015","unstructured":"Keating SE, Hackett DA, Parker HM, O\u2019Connor HT, Gerofi JA, Sainsbury A, et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatol. 2015;63(1):174\u201382.","journal-title":"J Hepatol"},{"issue":"1","key":"7385_CR64","doi-asserted-by":"publisher","first-page":"e001486","DOI":"10.1136\/bmjsem-2022-001486","volume":"9","author":"SB Nymand","year":"2023","unstructured":"Nymand SB, Hartmann J, Rasmussen IE, Iepsen UW, Ried-Larsen M, Christensen RH, et al. Fidelity and tolerability of two high-intensity interval training protocols in patients with COPD: a randomised cross-over pilot study. BMJ Open Sport Exerc Med. 2023;9(1):e001486.","journal-title":"BMJ Open Sport Exerc Med"},{"issue":"3","key":"7385_CR65","first-page":"496","volume":"40","author":"J Zhang","year":"2020","unstructured":"Zhang J, Lin S, Jiang D, Li M, Chen Y, Li J, et al. Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors? Liver Int Off J Int Assoc Study Liver. 2020;40(3):496\u2013508.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"2","key":"7385_CR66","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/hep.30857","volume":"71","author":"HSJ Choi","year":"2020","unstructured":"Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen BE, et al. Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B. Hepatol Baltim Md. 2020;71(2):539\u201348.","journal-title":"Hepatol Baltim Md"},{"issue":"2","key":"7385_CR67","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398.","journal-title":"J Hepatol."},{"issue":"11\u201312","key":"7385_CR68","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.nut.2016.04.001","volume":"32","author":"J Yao","year":"2016","unstructured":"Yao J, Zhou L, Hua X, Kong M, Chen Y, Duan Z. Effects of nucleos(t)ide analogs on body composition in HBV-infected men: An age- and BMI-matched, cross-sectional study. Nutr Burbank Los Angel Cty Calif. 2016;32(11\u201312):1206\u201310.","journal-title":"Nutr Burbank Los Angel Cty Calif"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07385-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07385-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07385-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:32:48Z","timestamp":1702600368000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07385-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7385"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07385-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The capital regions committee on health research ethics in Denmark with reference number H-21034236 assessed by the committee. The committee approved protocol version 1.3 on the 6th of December 2021 and protocol version 1.4 was approved on the 19th of July 2022. Written, informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"All authors gave their consent for publication. Informed consent materials for trial participants are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"398"}}